France Aesthetic Medicine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

France Aesthetic Medicine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The France aesthetic medicine market is expected to grow at a CAGR of 8.58% over the forecast period, 2022-2027.

The COVID-19 pandemic led to the cancellation or rescheduling of aesthetic treatment procedures owing to the high infectivity of the SARS-CoV-2 virus and lockdown restrictions by the government that had an impact on the aesthetic medicine market in France. For instance, according to an article published in February 2021, titled “COVID-19 and plastic surgery residency: A French experience”, owing to the strict lockdown imposed in the country, the COVID-19 epidemic has significantly changed how plastic surgeons practice throughout the world as well as France. Hence, COVID-19 is expected to have a significant impact on the studied market.

The aesthetic medicine market in France is expected to grow over the forecast period owing to the factors such as increasing awareness about cosmetic procedures and growing adoption of non- and minimally invasive aesthetic procedures. For instance, according to the 2020 report of the International Society of Aesthetic Plastic Surgery, France was one of the top fifteen countries in the world with the highest number of plastic surgeons in the country performing various cosmetic procedures in the country.

Further, the cosmetic procedure in the country is gaining traction in France which is further expected to have a positive impact on the studied market. For instance, according to an article published in September 2021, titled “What are the most performed cosmetic surgery operations in France?”, France is one of the major destinations where most buttock enlargement procedures are performed in the country. Also, as per the same source, in France, each year, 479 cosmetic surgery procedures are performed for 100,000 people as compared to other countries (166 interventions in Japan, 254 in the United Kingdom, or 69 in India).

Further, along with the increased awareness about the potential benefits of aesthetic procedures, people are also inclined toward the use of minimal or non-invasive procedures in aesthetic treatments. The popularity of non-invasive or minimally invasive techniques is increasing in France. The reason for significant inclination is that majority of the audiences perceive normal surgical treatments as painful and with high-risk factors. Thus, the growing adoption of non- or minimally invasive aesthetic procedures is fueling the growth of the French aesthetic medicine market.

Additionally, there has been an abundant rise in advertising, displaying the ‘before’ and ‘after’ differences of various aesthetic procedures, thereby, prompting the youth and middle-aged to undergo medical aesthetic procedures. Therefore, owing to the above-mentioned factors, the France aesthetic medicine market is expected to grow over the forecast period. However, Stringent Safety Regulations for Aesthetic Procedures and associated side-effects associated with procedures are expected to restrain the growth of the aesthetic medicine market in France during the forecast period.

Key Market TrendsDermal Filler is Expected to Have a Significant Share in the Market Over the Forecast Period

Dermal fillers are medical device implants used to help create a smoother and/or fuller appearance in the face, including nasolabial folds (the lines extending from the sides of the nose to the edges of the mouth), cheeks, chin, lips, and back of the hands. They are also referred to as injectable implants, soft tissue fillers, lip, and facial fillers, or wrinkle fillers. Different types of dermal fillers are used during aesthetic procedures for different purposes such as absorbable (temporary) fillers which are used for moderate to severe facial wrinkles and skin folds, such as nasolabial folds, augmentation (increased volume) of lips, cheeks, chin, and back of the hand, non-absorbable (permanent) fillers are approved for only nasolabial folds and cheek acne scars, correction of contour deficiencies, such as wrinkles and acne scars and others. Hence, owing to their diverse use in the aesthetics industry, dermal fillers are used widely and are expected to have a significant share in the French aesthetic medicine market over the forecast period.

In addition, the technological advancements in the area and the launch of new products by the companies operating in the region are further expected to boost market growth. For instance, in March 2021, Joonghun Pharmaceutical launched its premium cross-linked hyaluronic acid dermal filler, Artgaon which is CE market in the European market, and as per the company, Artgaon’s unique cross-linking technology allows doctors to enjoy an injection force of a mere 7-8 newtons that is smooth and consistent. Despite this, Artgaon boasts high elastic (G prime) and cohesive properties when inside the skin. Hence, due to the above-mentioned factors, dermal fillers are expected to have healthy growth over the forecast period.

Competitive Landscape

The France aesthetic medicine market is fragmented and moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are AbbVie Inc. (Allergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Sinclair Pharma PLC, Johnson & Johnson, and others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.